Moderna, Inc. (BVMF:M1RN34)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of BRL 55.26 billion. The enterprise value is 23.95 billion.

Market Cap	55.26B
Enterprise Value	23.95B

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	6.53%
Owned by Institutions (%)	72.72%
Float	364.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.65
PB Ratio	1.11
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.44
EV / Sales	2.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.69

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.08.

Current Ratio	3.93
Quick Ratio	3.51
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-432.88

Financial Efficiency

Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -18.54%.

Return on Equity (ROE)	-29.32%
Return on Assets (ROA)	-15.49%
Return on Invested Capital (ROIC)	-18.54%
Return on Capital Employed (ROCE)	-33.13%
Revenue Per Employee	2.05M
Profits Per Employee	-2.86M
Employee Count	5,800
Asset Turnover	0.16
Inventory Turnover	15.39

Taxes

Income Tax	-197.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.18% in the last 52 weeks. The beta is 1.11, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-49.18%
50-Day Moving Average	6.94
200-Day Moving Average	7.95
Relative Strength Index (RSI)	51.19
Average Volume (20 Days)	92,144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.68

Income Statement

In the last 12 months, Moderna had revenue of BRL 11.90 billion and -16.61 billion in losses. Loss per share was -42.91.

Revenue	11.90B
Gross Profit	-18.62B
Operating Income	-18.46B
Pretax Income	-16.80B
Net Income	-16.61B
EBITDA	-17.35B
EBIT	-18.46B
Loss Per Share	-42.91

Balance Sheet

The company has 24.00 billion in cash and 3.91 billion in debt, giving a net cash position of 31.51 billion.

Cash & Cash Equivalents	24.00B
Total Debt	3.91B
Net Cash	31.51B
Net Cash Per Share	n/a
Equity (Book Value)	49.72B
Book Value Per Share	127.17
Working Capital	26.20B

Cash Flow

In the last 12 months, operating cash flow was -10.54 billion and capital expenditures -3.60 billion, giving a free cash flow of -14.14 billion.

Operating Cash Flow	-10.54B
Capital Expenditures	-3.60B
Free Cash Flow	-14.14B
FCF Per Share	n/a

Margins

Gross margin is -156.54%, with operating and profit margins of -155.15% and -139.61%.

Gross Margin	-156.54%
Operating Margin	-155.15%
Pretax Margin	-141.26%
Profit Margin	-139.61%
EBITDA Margin	-145.83%
EBIT Margin	-155.15%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	-30.05%
FCF Yield	-25.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	2

Scores

Moderna has an Altman Z-Score of 3.5 and a Piotroski F-Score of 1.

Altman Z-Score	3.5
Piotroski F-Score	1